Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 6, 2026, 11:35 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1537–1560 of 121,474 matching trials from the live ClinicalTrials.gov search.

Filters: Completed Clear all

Conditions: Substance Use Disorders, Alcohol Use Disorder
Interventions: Woebot Substance Use Disorder; Other
Lead sponsor: Woebot Health; Industry
Eligibility: 18 Years to 65 Years
Enrollment: 180 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020
U.S. locations: 1
States / cities: Palo Alto, California

Conditions: Stress, Learning, Spatial
Interventions: Socially Evaluated Cold Pressor Test, Control; Behavioral
Lead sponsor: Yale University; Other
Eligibility: 18 Years to 45 Years
Enrollment: 106 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2024
U.S. locations: 1
States / cities: New Haven, Connecticut

Conditions: Lymphocytic Leukemia, Chronic
Interventions: obinutuzumab, rituximab, chlorambucil; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: 18 Years and older
Enrollment: 787 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2017
U.S. locations: 5
States / cities: San Diego, California • Chicago, Illinois • Baltimore, Maryland + 2 more

Conditions: Cardiovascular Disease, Acute Coronary Syndrome
Interventions: Multifaceted Intervention with pharmacist and IVR; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 91 Years
Enrollment: 14,573 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2014 – 2022
U.S. locations: 15
States / cities: Aurora, Colorado • Washington D.C., District of Columbia • Gainesville, Florida + 12 more

Conditions: HIV-Associated Lipodystrophy Syndrome, Insulin Resistance, HIV Infections, Metabolic Syndrome X, Body Weight Changes
Interventions: Rosiglitazone, Recombinant human growth hormone + rosiglitazone; Drug
Lead sponsor: Weill Medical College of Cornell University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 77 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2010
U.S. locations: 4
States / cities: New York, New York

Conditions: Parents
Interventions: easy to read fact sheets; Other
Lead sponsor: State University of New York - Upstate Medical University; Other
Eligibility: 18 Years and older
Enrollment: 23 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2005 – 2008
U.S. locations: 1
States / cities: Syracuse, New York

Conditions: Stress Disorders, Posttraumatic
Interventions: Hydrocortisone, D-Cycloserine, Placebo; Drug
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 65 Years
Enrollment: 111 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009 – 2015
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Traumatic Brain Injury
Interventions: Brain Training Program 1, Brain Training Program 2; Behavioral
Lead sponsor: The University of Texas at Dallas; Other
Eligibility: 19 Years to 65 Years
Enrollment: 108 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 1
States / cities: Dallas, Texas

Conditions: Carcinoma, Squamous Cell of Head and Neck
Interventions: AZD1775, Cisplatin, Intensity Modulated Radiotherapy Treatments; Drug · Radiation
Lead sponsor: UNC Lineberger Comprehensive Cancer Center; Other
Eligibility: 18 Years and older
Enrollment: 12 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2021
U.S. locations: 1
States / cities: Chapel Hill, North Carolina

Conditions: Diabetes
Interventions: Vessel measurements; Other
Lead sponsor: VA Office of Research and Development; Federal
Eligibility: 18 Years to 99 Years
Enrollment: 800 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Arrhythmia, Bradycardia
Interventions: Pacemaker; Device
Lead sponsor: Medtronic Cardiac Rhythm and Heart Failure; Industry
Eligibility: Not listed
Enrollment: 860 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2006
U.S. locations: 51
States / cities: Anchorage, Alabama • Mobile, Alabama • Fullerton, California + 48 more

Conditions: Athletic Injuries
Interventions: Intervention; Other
Lead sponsor: University of Mississippi Medical Center; Other
Eligibility: 18 Years and older
Enrollment: 75 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2019
U.S. locations: 1
States / cities: Jackson, Mississippi

Conditions: Essential Tremor, Tremor
Interventions: Ethanol, Propranolol; Other · Drug
Lead sponsor: University of California, San Diego; Other
Eligibility: 21 Years and older
Enrollment: 56 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: La Jolla, California

Conditions: Sexually Transmitted Diseases, Substance-Related Disorders
Interventions: Partner-Specific IMB-based HIV risk reduction intervention, Healthy Lifestyle; Behavioral
Lead sponsor: Women and Infants Hospital of Rhode Island; Other
Eligibility: 15 Years to 18 Years
Enrollment: 59 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 1
States / cities: Providence, Rhode Island

Conditions: Kidney Diseases
Interventions: Control, Protein, Protein + Exercise; Dietary Supplement · Behavioral
Lead sponsor: University of Illinois at Urbana-Champaign; Other
Eligibility: 30 Years to 80 Years
Enrollment: 138 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2018
U.S. locations: 2
States / cities: Chicago, Illinois • Urbana, Illinois

Conditions: Radiation Exposure
Interventions: lead-free protective drape containing bismuth and antimony (RADPAD®), sterile identical sham drape; Device
Lead sponsor: Yale University; Other
Eligibility: 45 Years to 50 Years
Enrollment: 2 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013
U.S. locations: 1
States / cities: New Have, Connecticut

Conditions: Major Depressive Disorder
Interventions: (2R,6R)-Hydroxynorketamine hydrochloride, Placebo; Drug
Lead sponsor: National Institute of Mental Health (NIMH); NIH
Eligibility: 18 Years to 65 Years
Enrollment: 74 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2021 – 2023
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Atrial Fibrillation, Coronary Artery Disease
Interventions: Regadenoson MRI, Gadobenate dimeglumine; Drug
Lead sponsor: University of Utah; Other
Eligibility: 18 Years to 100 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Salt Lake City, Utah

Conditions: Metastatic Breast Cancer
Interventions: Palbociclib + an aromatase inhibitor, Palbociclib + Letrozole, Letrozole; Drug
Lead sponsor: Pfizer; Industry
Eligibility: 18 Years and older · Female only
Enrollment: 813 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 1
States / cities: New York, New York

Conditions: Acute Stroke
Interventions: Rehabilitation Therapy on Experimental Robotic Table and standard of care, Rehabilitation Therapy as part of Standard of Care (Control); Device · Genetic
Lead sponsor: Bright Cloud International Corp; Industry
Eligibility: 50 Years to 85 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019
U.S. locations: 2
States / cities: North Brunswick, New Jersey • West Orange, New Jersey

Conditions: Healthy Subjects
Interventions: Marketed Nasal Strip, Prototype Nasal Dilator; Device
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 18 Years and older
Enrollment: 80 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2009
U.S. locations: 1
States / cities: Verona, New Jersey

Conditions: Acne Vulgaris
Interventions: IDP-123 Lotion, Tazorac Cream, Vehicle Lotion, Vehicle Cream; Drug
Lead sponsor: Bausch Health Americas, Inc.; Industry
Eligibility: 12 Years and older
Enrollment: 210 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 16
States / cities: Encinitas, California • Fremont, California • Los Angeles, California + 12 more

Conditions: Stable Coronary Artery Disease
Interventions: Selatogrel, Placebo; Drug
Lead sponsor: Viatris Innovation GmbH; Industry
Eligibility: 18 Years to 85 Years
Enrollment: 346 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 7
States / cities: Jacksonville, Florida • Tampa, Florida • Chicago, Illinois + 4 more

Conditions: Medical Errors, Electronic Medical Records
Interventions: Photo in Verification Alert, Photo in Banner, Photo in Banner and Verification Alert; Behavioral
Lead sponsor: Columbia University; Other
Eligibility: Not listed
Enrollment: 10,426 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2024
U.S. locations: 3
States / cities: Baltimore, Maryland • New York, New York

Search by objective public record fields.

W-SUDs for COVID-19

Influence of Stress on Encoding and Prediction

CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)

Hybrid Effectiveness-Implementation Study to Improve Clopidogrel Adherence

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

Parents Reading Comprehension of Their Child's Post-Operative Medicine Fact Sheets

Veteran Stress and Learning Study

Brain Training to Enhance Frontal Lobe Reasoning

Dose-escalating AZD1775 + Concurrent Radiation + Cisplatin for Intermediate/High Risk HNSCC

Retinal Vessel Measurements as Clinically Useful Predictors in Veterans

CAPTURE - Complete Automatic Pacing Threshold Utilization Recorded by EnPulse

Training for Injury Prevention in Collegiate Soccer Players

Functional Imaging of Tremor Circuits and Mechanisms of Treatment Response

Partner-Specific HIV Risk Reduction Intervention for Drug-Using Adolescents

Intra Hemodialytic Oral Protein and Exercise (IHOPE)

Digestive Endoscopy Suite Radiation Controlling Protective Strategies

Phase 1 Evaluation of (2R,6R)-Hydroxynorketamine

Regadenoson Stress-MRI to Identify Coronary Artery Disease in Atrial Fibrillation Patients

Real-world Treatment Patterns and Effectiveness of Palbociclib and AI Therapy

Arm Motor Rehabilitation, Entertainment and Cognition System for the Elderly (Clinical Trial)

A Multiple Use Tolerability Study of a Breathe Right Nasal Strip Prototype

Safety and Efficacy of IDP-123 Lotion to Tazorac® Cream, in the Treatment of Acne Vulgaris

A Medical Research Study to Evaluate the Effects of ACT-246475 in Adults With Coronary Artery Disease

Evaluating the Impact of Patient Photographs for Preventing Wrong-Patient Errors